These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35201504)

  • 1. Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance.
    Tonse R; Rubens M; Appel H; Tom MC; Hall MD; Odia Y; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha R
    Discov Oncol; 2021 Nov; 12(1):48. PubMed ID: 35201504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of PD-L1 expression discordance between primary tumor and lung cancer brain metastasis.
    Tonse R; Rubens M; Appel H; Tom MC; Hall MD; Odia Y; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha R
    Neurooncol Adv; 2021; 3(1):vdab166. PubMed ID: 34988451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance.
    Kotecha R; Tonse R; Rubens M; McDermott MW; Odia Y; Appel H; Mehta MP
    Neurooncol Adv; 2021; 3(1):vdab010. PubMed ID: 33898990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer.
    Quéré G; Descourt R; Robinet G; Autret S; Raguenes O; Fercot B; Alemany P; Uguen A; Férec C; Quintin-Roué I; Le Gac G
    BMC Cancer; 2016 Mar; 16():210. PubMed ID: 26968843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis].
    Han C; Zou H; Ma J; Zhou Y; Zhao J
    Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):882-91. PubMed ID: 20840818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
    Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
    Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: A systematic review and meta-analysis.
    Lee CC; Soon YY; Tan CL; Koh WY; Leong CN; Tey JCS; Tham IWK
    PLoS One; 2019; 14(6):e0218414. PubMed ID: 31216329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted sequencing reveals distinct pathogenic variants in Chinese patients with lung adenocarcinoma brain metastases.
    Ma Y; Chen K; Yang Z; Guan M
    Oncol Lett; 2018 Apr; 15(4):4503-4510. PubMed ID: 29541220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
    Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
    J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance of Epidermal Growth Factor Receptor Mutation between Brain Metastasis and Primary Non-Small Cell Lung Cancer.
    Kim KM; Lee SH; Kim SM; Kim NY; Gwak HS; Shin SH; Kwon JW; Yoo H
    Brain Tumor Res Treat; 2019 Oct; 7(2):137-140. PubMed ID: 31686445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of epidermal growth factor receptor and KRAS gene status between primary and corresponding metastatic tumours of non-small cell lung cancer.
    Wang S; Wang Z
    Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):30-9. PubMed ID: 25445553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.
    Neumann J; Wehweck L; Maatz S; Engel J; Kirchner T; Jung A
    Virchows Arch; 2013 Oct; 463(4):509-23. PubMed ID: 23934607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
    Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
    J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.
    Karimpour M; Ravanbakhsh R; Maydanchi M; Rajabi A; Azizi F; Saber A
    Biomed Pharmacother; 2021 Nov; 143():112190. PubMed ID: 34560543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutation status in primary nonsmall cell lung cancer and matched metastases.
    Cortot AB; Italiano A; Burel-Vandenbos F; Martel-Planche G; Hainaut P
    Cancer; 2010 Jun; 116(11):2682-7. PubMed ID: 20336783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
    Arrieta O; Ramírez-Tirado LA; Caballé-Perez E; Mejia-Perez A; Zatarain-Barrón ZL; Cardona AF; Lozano-Ruíz F; Segura-González M; Cruz-Rico G; Maldonado F; Rosell R
    Thorac Cancer; 2020 Apr; 11(4):1026-1037. PubMed ID: 32072746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 discordance between paired primary gastric cancer and metastasis: a meta-analysis.
    Peng Z; Zou J; Zhang X; Yang Y; Gao J; Li Y; Li Y; Shen L
    Chin J Cancer Res; 2015 Apr; 27(2):163-71. PubMed ID: 25937778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance of epidermal growth factor receptor mutations between primary tumors and corresponding mediastinal nodal metastases in patients operated on for stage N2 non-small cell lung cancer.
    Fang Q; Yang H; Ou W; Ye X; Zhang BB; Sun HB; Zhang L; Cao X; Wang SY
    Thorac Cancer; 2012 Nov; 3(4):313-319. PubMed ID: 28920283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L
    Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.